News
Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of ...
7h
Medpage Today on MSNThe Future of ART Regimens for HIV Is in Long-Acting AgentsRecent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...
The neuroendocrine prostate cancer treatment space will experience significant changes during the forecast period of 2025–2034, owing to the launch o ...
A mum who enrolled in a college course after her son’s type 1 diabetes diagnosis is now building a successful career in science after 20 years ...
6don MSN
The dollar (.DXY) is on course for its best week of the year, as unfolding U.S. trade deals are succeeding in raising tariffs ...
Employees of the technology transfer centre ANAXAM and researchers from the Paul Scherrer Institute PSI used the unique ...
4d
News-Medical.Net on MSNZinc from needle shields may contribute to syringe cloggingEmployees of the technology transfer centre ANAXAM and researchers from the Paul Scherrer Institute PSI used the unique ...
Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build ...
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep” or 'the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an upcoming poster presentation for ...
Global Antibody Discovery Market To Observe Stupendous Growth At A CAGR Of ~10% By 2032 Delveinsight
The antibody discovery market is expanding, driven by the increasing incidence of chronic conditions such as cancer, diabetes, and cardiovascular and ...
US President Donald Trump said on Thursday he would delay the higher rate of reciprocal tariffs on Mexico by 90 days.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results